Inovio Pharma (INO) Misses Q4 EPS by $1.13
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $0.90 --0%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($1.45), $1.13 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $2.84 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
